Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

DOI: 10.1038/s41531-018-0051-7

Full-Text   Cite this paper   Add to My Lib

Abstract:

Overview of the two FDA-approved OM device

Full-Text